methylene blue has been researched along with Retinal Neovascularization in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Contartese, DS; Dorfman, VB; Fernández, JC; Inserra, PI; Larrayoz, IM; Loidl, CF; López-Costa, JJ; Martínez, A; Martínez-Murillo, R; Rey-Funes, M; Rolón, F | 1 |
1 other study(ies) available for methylene blue and Retinal Neovascularization
Article | Year |
---|---|
Methylene blue prevents retinal damage in an experimental model of ischemic proliferative retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antioxidants; Dose-Response Relationship, Drug; Male; Methylene Blue; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retinal Neovascularization; Retinopathy of Prematurity; Treatment Outcome | 2016 |